Answers are grounded in this paper and cite their sources.
Critiques reveal associations between limited clinical evidence in manufacturers' submissions and negative recommendations for oncology medications.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jadid et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: